ENTITY
Roche Holding

Roche Holding (ROG SW)

112
Analysis
Health Care • United States
Roche Holding AG develops and manufactures pharmaceutical and diagnostic products. The Company produces prescription drugs in the areas of cardiovascular, infectious, autoimmune, respiratory diseases, dermatology, metabolic disorders, oncology, transplantation, and the central nervous system. Roche Holding serves customers worldwide.
more
•06 Nov 2020 09:55

Insights on China Genetic Testing Industry

This article analyzed China genetic testing industry in the perspective of favorable policy, market potential, future trend, investment trend in...

Logo
592 Views
Share
•22 Jun 2026 08:30

Alebund Pharmaceuticals IPO: Late Stage Differentiated Pipeline Lend Conviction on Commercialization

Alebund Pharmaceuticals has launched HK IPO consisting of 57M H shares at HK$22.60 per share to fund the ongoing and planned clinical development...

Logo
154 Views
Share
•23 Mar 2020 06:45

🇯🇵 JAPAN MARKET UPDATE • Hit the BoJ Bid and Wait for the Absolute Value Opportunity

TAKE PROFITS - Japanese equities, as measured by the TOPIX Index, rose by 1.7% over the last week in Yen terms and fell by only 0.86% in US...

Logo
542 Views
Share
•17 Jun 2026 12:45

Liquid Universe of European Ordinary and Preferred Shares: June '26 Report

June brought renewed divergence across European ord/pref pairs. Structural outliers widened, convergence became more selective, and implementation...

Share
•02 Mar 2020 11:08

🇯🇵 JAPAN • March Company Relative Price Scores - Playing the Extremes

 • RELATIVE PRICE SCORE - COMPANIES • RELATIVE PRICE SCORE OUTLIERS - The Relative Price Score (RPS) is a measure of price performance relative to...

Logo
490 Views
Share
x